Real-time enrollment status for this recurrent glioblastoma, idh-wildtype clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 11:38 AM UTC
| NCT Number | NCT05432804 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Glioblastoma, IDH-Wildtype |
| Phase | PHASE1 |
| Target Enrollment | 97 participants |
| Active Locations | 36 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | August 26, 2026 (Yesterday) |
As of August 27, 2026: Clinical trial NCT05432804 is currently recruiting participants. This phase1 study for recurrent glioblastoma, idh-wildtype is actively seeking new participants at 36 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05432804 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 36 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05432804 was last updated Yesterday (August 26, 2026). HelloStudys verifies this status automatically.